TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Accumulated morphine usage dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of infection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Categorization accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-alternative forced choice accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-alternative forced choice reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients responding to the FACIT Fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: modified Rankin score at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal stability of motor function using gait speed measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Longitudinal stability of motor function using 10 meter walk/run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Longitudinal stability of motor function using Timed Up and Go (TUG) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Longitudinal stability of motor function using the Dynamic Gait Index (DGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of encounters with anorectal physiology testing ordered or performed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of encounters with pelvic floor physical therapy ordered
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Alcohol consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total dose of opioid consumption (tramadol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma decitabine concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre-operative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-operative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective Pre-operative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Post-operative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-procedure Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Longitudinal changes in left and right ventricular global strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence, severity and duration of solicited systemic adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence, severity and duration of local adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of unsolicited treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Distance visual acuity with study lenses at 1-year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of fecal short chain fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum peptide tyrosine tyrosine (PYY)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urodynamic study (intravesical pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urodynamic study (detrusor pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAQDI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maternal Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in Physician's Global Assessment (PGA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ichthyosis Scoring System (ISS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous biologic neo-conduit development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anastomotic leak or fistula requiring non-endoscopic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Need for fallback emergency esophagectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Death within 30 days of index procedure
Endpoint domain: Mortality/survival
Primary endpoint: Physiological Parameters Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Symptom Severity and Incidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Disease Activity Score (DAS) 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating of perceived exertion (Borg Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of satisfaction and acceptability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: St. George's Respiratory Questionnaire, SGRQ
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Determination of maximum tolerated dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events as assessed by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of anti-platelet factor 4 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of arterial and/or venous thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Ratio (%) of valid tests/performed tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of Test Performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Comfort to participants
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: One repetition maximum in bench press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One repetition maximum in shoulder press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of the trochlear groove
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extracellular water for volume status characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completeness of data verification
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent concordance of rapid genotyping of SNPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypnotic Induction Profile score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Theoretical Evaluation Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Spontaneous Preterm Birth < 34 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Delivery within seven days after inclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vaginal health index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Female Sexual Distress Scale (FSD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postprocedure surgical challenges rate
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve of the model predicting response to rTMS treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-spike (S1) IgG concentration against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: anti-MenACWY IgG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Typhoid IgG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Non-response to exposure-based therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of sleep bruxism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fidelity to the Intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Meaning in Life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported readiness for behavioural change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduction in red blood cell transfusion burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Implant Stability Quotient (ISQ) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone-implant contact surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary insertion torque value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in replacing phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fracture diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle mass changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: prevalence of metastatic involvement in intrathoracic lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: High-Activity Arthroplasty Score (HAAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in knowledge about echocardiograms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in confidence in getting an echocardiogram
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in perceived choice of getting an echocardiogram
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in social norms influence on decision
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in movement toward screening
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Differences in time spent in physical activity intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Setup error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent change in lumbar spine bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum IL-1 Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum IL-15 Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PARP-1 mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Modified Mallampati Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of frozen sections sent for analysis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fear response directly post-extinction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear response 24 hours post-extinction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain inhibition control networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of subjects retaining left ventricular ejection fraction >=45% at 12 months post-LVAD weaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term safety of KT-301
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical efficacy of KT-301
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinically relevant postoperative pancreatic fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: In sit Smash
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jump smash
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of MBE
Endpoint domain: Adverse events/effects
Primary endpoint: Balance, gait and risk of falling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAP value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total bile acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in secondary bile acids:primary bile acids ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in conjugated:unconjugated BAs ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Fugl-Meyer assessment for motor function of upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Speed of Walking 400 Meters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge and attitude towards Preconception care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Apparent plasma terminal elimination half-life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Pain Inventory, Short Form (BPI-SF) Change
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Hamilton-Depression Inventory (HAM-D) Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to last dose of intravenous vancomycin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cumulative Clinical Pregnancy Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight gain from baseline to 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of RNA transcripts from blood cells and fibroblasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of metallic taste
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Xpert MTB/XDR assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Specificity of Xpert MTB/XDR assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Change in Number of Referrals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants with Protocol Specified Dose-Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Adverse Events and Clinical Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Area Under the Concentration-Time Curve of MK-2214 from Time 0 to 28 Hours (AUC0-28) After First and Third Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD)/recommended extended dose (RDE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anaphylaxis occurrence rates
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal muscle oxidative capacity (mVO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular endurance of the gastrocnemius muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Urine Porphobilinogen/creatinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain score at recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Spinal Injury Association Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PrEP penetration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plantar sensation - Tactile sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar sensation - Vibration sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance and Gait - Tinetti Balance And Gait Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects with Dose-Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Structural changes in the placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional changes in the placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cocaine-positive urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported cocaine use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cotinine levels in urine changes from baseline to post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right-Left Discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Compliance with 24-hour movement behaviour guidelines
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Restoration of femoral hip offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody based immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Yale-Brown Obsessive-Compulsive Scale - Self-Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quick Inventory of Depressive Symptomology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical assessment outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sense of touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperactivity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention deficit/hyperactivity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular irritation symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functions related to vision
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of Surgical Site Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Motor Function Assessment System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-Seconds Grab and Release Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of BC006
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended Dose for Expansion (RDE) of BC006
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood cellular NAD+/ NADH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Six walking endurance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary 68Ga-Dotatate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline body weight at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time up and go test (TUG test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 Times Sit to stand test (5TSTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of rehospitalization for worsened heart failure and cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Area under curve of the differential diagnosis of sbORN and NPC recurrence delivered by the deep-learning-based multimodal model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve of the differential diagnosis of sbORN and NPC recurrence delivered by the radiologists
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic Communication Skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Integrity of colonoscopy report
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Record mortality
Endpoint domain: Mortality/survival
Primary endpoint: Health care quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life